PropertyValue
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/ns/prov#value
  • have no rights or obligations with respect to the Development (including manufacturing development) of Anti-IgE Antibodies or Anti-IgE Products for Commercialization in East Asia and ROW other than as expressly set forth in this Agreement.
http://www.w3.org/ns/prov#wasQuotedFrom
  • sec.gov